Axsome Therapeutics, Inc. · NASDAQ:AXSM
Coleman Mark sold 643 Axsome Therapeutics, Inc. shares (Form 4)
Traded Jun 8 to Jun 10, 2026 · Filed Jun 10, 2026
From Jun 8 to Jun 10, 2026, Coleman Mark (Director) sold 643 Axsome Therapeutics, Inc. shares at US$249.00 for US$160K under a trading plan, leaving 30,389 shares. Filed Jun 10, 2026 (Form 4).
- Sold
- 643 shares
- Price
- US$249.00
- Value
- US$160K
- Holding after
- 30,389 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 8, 2026 | Common Stock | Option exercise | 1,429 | 31,032 | Direct | |
| Jun 10, 2026 | Common Stock | Sale | 643 | US$249.00 | 30,389 | Direct |
Source
Related
- Axsome Therapeutics, Inc.
- Coleman Mark
- Axsome Therapeutics, Inc. shareholders
- Form 4 · Coleman Mark · Jun 2, 2026
- Form 4 · Jacobson Mark L. · Sep 3, 2026
- Form 4 · Tabuteau Herriot · Aug 7, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 27, 2026
- Form 4 · Tabuteau Herriot · Jul 1, 2026
- Form 4 · Jeffs Roger · Jun 11, 2026